Treatment of advanced seminoma with cyclophosphamide, vincristine and carboplatin on an outpatient basis.

This study describes the efficacy and toxicity of a combination regimen consisting of cyclophosphamide, vincristine (oncovin) and carboplatin (COC) for advanced seminoma on an outpatient basis. Twenty-seven patients (mean age 43 years, range 28-63 years) were classified as stage IIC (n = 5), stage I...

Descripción completa

Detalles Bibliográficos
Autores principales: Sleijfer, S., Willemse, P. H., de Vries, E. G., van der Graaf, W. T., Schraffordt Koops, H., Mulder, N. H.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1996
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074753/
https://www.ncbi.nlm.nih.gov/pubmed/8826863

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074753/
https://www.ncbi.nlm.nih.gov/pubmed/8826863

Ejemplares similares